Plasmacytoma, NOS: Difference between revisions

m Text replacement - "== Alternate ICD10s to consider coding instead or in addition ==" to "{{ICD10 Guideline Cancer}} == Alternate ICD10s to consider coding instead or in addition =="
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{ICD10 transition status
{{ICD10 transition status
| OldDxArticle =
| OldDxArticle =
| CurrentStatus = freshly automatically generated article
| CurrentStatus = reconciled
| InitialEditorAssigned = Debbie Page-Newton
| InitialEditorAssigned = Debbie Page-Newton
}}
}}
Line 9: Line 9:
| BugRequired=  
| BugRequired=  
}}
}}
{{ICD10 category|Heme/immunology}}{{ICD10 category|Neoplastic}}  
{{ICD10 category|Heme/immunology}}{{ICD10 category|Neoplastic}}{{ICD10 category|Heme/immunology neoplasm}}  


== Additional Info ==
== Additional Info ==
{sc:multiple myeloma}
https://en.wikipedia.org/wiki/Plasmacytoma
*Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue or within the axial skeleton.
*Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue or within the axial skeleton.
*The International Myeloma Working Group lists three types:  
*The International Myeloma Working Group lists three types:  
**solitary plasmacytoma of bone (SPB)  
**solitary plasmacytoma of bone (SPB)  
**extramedullary plasmacytoma (EP)  
**extramedullary plasmacytoma (EP)  
**multiple plasmacytomas that are either primary or recurrent.
**multiple plasmacytomas that are either primary or recurrent.
*The most common of these is SPB, accounting for 3–5% of all plasma cell malignancies. SPBs occur as lytic lesions within the axial skeleton and extramedullary plasmacytomas most often occur in the upper respiratory tract (85%), but can occur in any soft tissue. Approximately half of all cases produce paraproteinemia. SPBs and extramedullary plasmacytomas are mostly treated with radiotherapy, but surgery is used in some cases of extramedullary plasmacytoma. The skeletal forms frequently progress to multiple myeloma over the course of 2–4 years.


Due to their cellular similarity, plasmacytomas have to be differentiated from multiple myeloma. For SPB and extramedullary plasmacytoma the distinction is the presence of only one lesion (either in bone or soft tissue), normal bone marrow (<5% plasma cells), normal skeletal survey, absent or low paraprotein and no end organ damage.
{{ICD10 Guideline Cancer}}


== Alternate ICD10s to consider coding instead or in addition ==
== Alternate ICD10s to consider coding instead or in addition ==
* [[Multiple myeloma]]
{{ListICD10Category | categoryName = Heme/immunology neoplasm}}


== Candidate [[Combined ICD10 codes]] ==
== Candidate [[Combined ICD10 codes]] ==


== Related CCI Codes ==
== Related CCI Codes ==
{{Data Integrity Check List}}


== Related Articles ==
== Related Articles ==
{{Related Articles}}
{{Related Articles}}


{{ICD10 footer}}
{{ICD10 footer}}
{{EndPlaceHolder}}
{{EndPlaceHolder}}